Gassert Chad's most recent trade in ANI Pharmaceuticals Inc was a trade of 11,116 Common Stock done at an average price of $77.1 . Disclosure was reported to the exchange on Feb. 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 77.15 per share. | 26 Feb 2026 | 11,116 | 77,137 (0%) | 0% | 77.1 | 857,599 | Common Stock |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.90 per share. | 26 Feb 2026 | 2,221 | 74,916 (0%) | 0% | 73.9 | 164,132 | Common Stock |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.36 per share. | 12 Feb 2026 | 1,717 | 66,021 (0%) | 0% | 77.4 | 132,827 | Common Stock |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.70 per share. | 12 Feb 2026 | 1,608 | 67,738 (0%) | 0% | 76.7 | 123,334 | Common Stock |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.25 per share. | 11 Feb 2026 | 4,269 | 69,346 (0%) | 0% | 76.2 | 325,511 | Common Stock |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 89.07 per share. | 12 Nov 2025 | 14,642 | 158,584 (1%) | 0% | 89.1 | 1,304,163 | Common Stock |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 88.00 per share. | 12 Nov 2025 | 94 | 158,490 (1%) | 0% | 88 | 8,272 | Common Stock |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 86.97 per share. | 15 Aug 2025 | 20,000 | 173,226 (1%) | 0% | 87.0 | 1,739,400 | Common Stock |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 14,362 | 64,041 (0%) | 0% | 0 | Common Stock | |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 9,574 | 73,615 (0%) | 0% | 0 | Common Stock | |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 63.44 per share. | 01 Jul 2024 | 20,000 | 193,226 (1%) | 0% | 63.4 | 1,268,800 | Common Stock |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 64.41 per share. | 03 Jun 2024 | 20,000 | 213,226 (1%) | 0% | 64.4 | 1,288,200 | Common Stock |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 66.62 per share. | 01 May 2024 | 20,000 | 233,226 (1%) | 0% | 66.6 | 1,332,400 | Common Stock |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 67.25 per share. | 01 Apr 2024 | 20,000 | 253,226 (2%) | 0% | 67.3 | 1,345,000 | Common Stock |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 65.81 per share. | 11 Mar 2024 | 20,000 | 273,226 (2%) | 0% | 65.8 | 1,316,200 | Common Stock |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.67 per share. | 29 Feb 2024 | 1,635 | 49,679 (0%) | 0% | 67.7 | 110,640 | Common Stock |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 13,421 | 42,368 (0%) | 0% | 0 | Common Stock | |
| ANI Pharma Inc | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 8,946 | 51,314 (0%) | 0% | 0 | Common Stock | |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 51.06 per share. | 01 Aug 2023 | 20,000 | 333,226 (2%) | 0% | 51.1 | 1,021,200 | Common Stock |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 53.43 per share. | 03 Jul 2023 | 20,000 | 353,226 (2%) | 0% | 53.4 | 1,068,600 | Common Stock |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 17,369 | 17,369 (0%) | 0% | 0 | Common Stock | |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 11,578 | 28,947 (0%) | 0% | 0 | Common Stock | |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Purchase of securities on an exchange or from another person at price $ 27.87 per share. | 18 Mar 2022 | 5,000 | 393,226 (3%) | 0% | 27.9 | 139,343 | Common Stock |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Purchase of securities on an exchange or from another person at price $ 27.15 per share. | 18 Mar 2022 | 5,000 | 388,226 (3%) | 0% | 27.1 | 135,744 | Common Stock |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 383,226 | 383,226 (3%) | 3% | - | Common Stock |